Key takeawaysUCLA researchers have developed a CAR-NKT cell therapy that has shown to be more effective than current ...

A team of researchers in California studied a new multi-cancer early detection test called Galleri, which can reportedly ...

Discover groundbreaking research on pulmonary fibrosis and a potential new treatment target that could revolutionize lung ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new long-term data highlighting the sustained survival benefits of KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 ...

Liposarcoma market growth is driven by increasing awareness and earlier diagnosis, expanding the pool of treatable patients. Advances in molecular profiling and targeted therapies ...

DelveInsight's Liposarcoma Market Insights report includes a comprehensive understanding of current treatment practices, ...

In the past 10 years, these scans have saved 80,000 years of life – that's nearly 30 million more days spent with loved ones ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced landmark results demonstrating ...

More Than Half of Cancers Detected by Galleri Were Early Stage Approximately Three-Quarters of Galleri-Detected Cancers Do Not Have Recommended Screenings ...

Virginia Mason Franciscan Health and the Seattle Seahawks team up to promote early cancer detection. Sponsored by Virginia ...